Nurish.Me Inc. Releases Audited Financial Statements for 2017 and 2018
Nurish.Me Inc. Releases Audited Financial Statements for 2017 and 2018 |
[08-December-2019] |
LA JOLLA, Calif., Dec. 8, 2019 /PRNewswire/ -- Nurish.Me Inc. (Subsidiary - F/K/A Altavoz Entertainment, Inc.; OTC Pink: AVOZ) (the "Company"), an emerging leader in the dietary supplement industry for delivering clinically proven solutions for brain and immune system support, announces the release of its audited financial statements for 2017 and 2018. The Company's management is now diligently working on preparing its financial report for 2019. Company CEO David Perez commented, "While the task of preparing and filing our financial statements has been a long and challenging process due to the reverse merger on December 18, 2018, we appreciate the thorough manner in which our independent accountants and auditing firm conducted their audit." "The continuing support of our shareholders and investors has allowed us to raise more than $3.4 million in equity and debt since May 2017, which has been partly utilized to develop clinically proven formulations that have been tested by five independent third-party analytical firms for their safety, purity, and integrity. In addition, funding was allocated to optimize our proprietary nanotechnology platform. Our intention is to make future investments in translational and clinical trials, thereby generating higher revenues on our path to profitability, while underscoring our corporate mission that is backed by science." About Nurish.Me Safe Harbor Contact
View original content:http://www.prnewswire.com/news-releases/nurishme-inc-releases-audited-financial-statements-for-2017-and-2018-300971086.html SOURCE Nurish.Me Inc. | ||
Company Codes: OTC-PINK:AVOZ |
© 2019 PR Newswire. All Rights Reserved.